|
Genotype frequency |
|||
| ESR Xba I |
CONTROL |
DDH |
PPA |
|
|
|||
| XX |
33(37.9%) |
24(55.8%) |
6(30%) |
| Xx |
45(51.7%) |
18(41.9%) |
12(60%) |
| xx |
9(10.3) |
1(2.3%) |
2(10%) |
| ESR Pvu II |
|||
| PP |
14(15.2%) |
4(8.9%) |
5(25%) |
| Pp |
47(51.1%) |
27(60%) |
11(55%) |
| pp |
31(33.7%) |
14(31.1%) |
4(20%) |
| VDR Fok I |
|||
| FF |
33(34.4%) |
15(33.3%) |
8(42.1%) |
| Ff |
52(54.2%) |
20(44.4%) |
9(47.4%) |
| ff |
11(11.5%) |
10(22.2%) |
2(10.5%) |
| VDR Taq I |
|||
| TT |
31(34.1%) |
18(41.9%) |
7(43.8%) |
| Tt |
46(50.5%) |
20(46.5%) |
5(31.3%) |
| tt |
14(15.4%) |
5(11.6%) |
4(25%) |
Kapoor et al. Journal of Negative Results in BioMedicine 2007 6:7 doi:10.1186/1477-5751-6-7 |
|||